Article
Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma.
PloS one - 29 Apr 2011
Minmin Shi, Xiaoqian Xu, Hao Chen, Baiyong Shen, Xiaxing Deng, Junjie Xie, Xi Zhan, Jianquan Zhao, Songyao Jiang
Abstract excerpt
BACKGROUND: Toll-like receptor 4 (TLR4) is a key innate immunity receptor that initiates an inflammatory response. Growing evidence suggests that mutation of TLR4 gene may play a role in the development of cancers. This study aimed to investigate the temporal relationship of single nucleotide polymorphisms of TLR4 and the risk of hepatocellular carcinoma, a single center-based case-control study was conducted....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
